[Federal Register Volume 71, Number 207 (Thursday, October 26, 2006)]
[Notices]
[Pages 62594-62595]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: E6-17932]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration


Dental Products Panel of the Medical Devices Advisory Committee; 
Notice of Meeting

AGENCY: Food and Drug Administration, HHS.

ACTION: Notice.

-----------------------------------------------------------------------

    This notice announces a forthcoming meeting of a public advisory 
committee of the Food and Drug Administration (FDA). At least one 
portion of the meeting will be closed to the public.
    Name of Committee: Dental Products Panel of the Medical Devices 
Advisory Committee.
    General Function of the Committee: To provide advice and 
recommendations to the agency on FDA's regulatory issues.
    Date and Time: The meeting will be held on November 9, 2006, from 8 
a.m. to 5 p.m.
    Location: Holiday Inn, Walker/Whetstone Rooms, Two Montgomery 
Village Ave., Gaithersburg, MD.
    Contact Person: Michael J. Ryan, Center for Devices and 
Radiological Health (HFZ-480), Food and Drug Administration, 9200 
Corporate Blvd., Rockville, MD 20850, 301-827-5283, ext. 175, e-mail 
at: [email protected], or FDA Advisory Committee Information 
Line, 1-800-741-8138 (301-443-0572 in the Washington, DC area), code 
3014512518. Please call the Information Line for up-to-date information 
on this meeting.
    Agenda: The committee will discuss, make recommendations, and vote 
on a premarket approval application for a collagen material, which 
contains a bone morphogenetic protein, for oral maxillofacial bone 
grafting procedures. Background information, including the agenda and 
questions for the committee, will be available to the public 1 business 
day before the meeting on the Internet at http://www.fda.gov/cdrh/panel 
(click on Upcoming CDRH Advisory Panel/Committee Meetings).
    Procedure: On November 9, 2006, from 8:30 a.m. to 5 p.m., the 
meeting will be open to the public. Interested persons may present 
data, information, or views, orally or in writing, on issues pending 
before the committee. Written submissions may be made to the contact 
person on or before November 2, 2006. Oral presentations from the 
public will be scheduled for approximately 30 minutes at the beginning 
of committee deliberations and for approximately 30 minutes near the 
end of the deliberations. Time allotted for each presentation may be 
limited. Those desiring to make formal oral presentations should notify 
the contact person and submit a brief statement of the general nature 
of the evidence or arguments they wish to present, the names and 
addresses of proposed participants, and an indication of the 
approximate time requested to make their presentation on or before 
November 2, 2006.
    Closed Committee Deliberations: On November 9, 2006, from 8 a.m. to 
8:30 a.m., the meeting will be closed to the public to permit FDA to 
present to the committee trade secret and/or confidential commercial 
information regarding pending and future agency issues (5 U.S.C. 
552b(c)(4)) for the next year.
    Persons attending FDA's advisory committee meetings are advised 
that the agency is not responsible for providing access to electrical 
outlets.
    FDA welcomes the attendance of the public at its advisory committee 
meetings and will make every effort to accommodate persons with 
physical disabilities or special needs. If you require special 
accommodations due to a disability, please contact AnnMarie Williams, 
Conference Management Staff, 301-827-7291, at least 7 days in advance 
of the meeting.
    FDA regrets that it was unable to publish this notice 15 days prior 
to the Dental Products Panel of the Medical Devices Advisory Committee 
meeting. Because the agency believes there is some urgency to bring 
these issues to public discussion and qualified members of the Dental 
Products Panel of the Medical Devices Advisory Committee were available 
at this time, the Commissioner of Food and Drugs concluded that it was 
in the public interest to hold this meeting even if there was not 
sufficient time for the customary 15-day public notice.
    Notice of this meeting is given under the Federal Advisory 
Committee Act (5 U.S.C. app. 2).


[[Page 62595]]


    Dated: October 23, 2006.
Randall W. Lutter,
Associate Commissioner for Policy and Planning.
[FR Doc. E6-17932 Filed 10-25-06; 8:45 am]
BILLING CODE 4160-01-S